Morningstar

PGIM Jennison Health Sciences C PHLCX

Morningstar Medalist Rating
Medalist Rating as of | See PGIM Investment Hub
  • NAV / 1-Day Return 19.11  /  −0.68 %
  • Total Assets 1.8 Bil
  • Adj. Expense Ratio
    1.980%
  • Expense Ratio 1.980%
  • Distribution Fee Level Average
  • Share Class Type Level Load
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.00
  • Turnover 64%

USD | NAV as of Sep 26, 2024 | 1-Day Return as of Sep 26, 2024, 12:34 AM GMT+0

Morningstar’s Analysis PHLCX

Will PHLCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable PHLCX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the PHLCX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of PHLCX’s parent organization’s priorities and whether they’re in line with investors’ interests.

Considered, bold approach invites risks.

Senior Analyst Chris Tate

Chris Tate

Senior Analyst

Summary

Jennison Health Sciences’ vast analytical resources and thoughtful approach combine for a bold but appealing healthcare offering.

by Chris Tate
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PHLCX

More PHLCX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 50.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

13.70 264.7 Mil
Healthcare

UnitedHealth Group Inc

4.96 95.8 Mil
Healthcare

Amgen Inc

4.85 93.8 Mil
Healthcare

Bristol-Myers Squibb Co

4.80 92.8 Mil
Healthcare

Vertex Pharmaceuticals Inc

4.78 92.3 Mil
Healthcare

Novo Nordisk AS ADR

3.92 75.8 Mil
Healthcare

Boston Scientific Corp

3.44 66.5 Mil
Healthcare

argenx SE ADR

3.44 66.4 Mil
Healthcare

Humana Inc

3.39 65.6 Mil
Healthcare

AstraZeneca PLC ADR

3.38 65.3 Mil
Healthcare

Sponsor Center